End-of-day quote
Korea S.E.
23:00:00 06/06/2024 BST
|
5-day change
|
1st Jan Change
|
5,420
KRW
|
-3.90%
|
|
-11.29%
|
+48.29%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
75,863
|
76,957
|
86,764
|
80,050
|
72,045
|
66,496
|
Enterprise Value (EV)
1 |
115,165
|
109,760
|
119,657
|
109,753
|
121,381
|
106,240
|
P/E ratio
|
-0.99
x
|
2.08
x
|
1.09
x
|
2.81
x
|
1.88
x
|
-22.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.94
x
|
0.85
x
|
0.99
x
|
0.85
x
|
0.67
x
|
0.51
x
|
EV / Revenue
|
1.43
x
|
1.21
x
|
1.37
x
|
1.16
x
|
1.12
x
|
0.82
x
|
EV / EBITDA
|
39.3
x
|
16.2
x
|
17.4
x
|
11.9
x
|
12.6
x
|
7.28
x
|
EV / FCF
|
-44.7
x
|
36.9
x
|
16.2
x
|
25.5
x
|
-6.96
x
|
17.2
x
|
FCF Yield
|
-2.24%
|
2.71%
|
6.16%
|
3.92%
|
-14.4%
|
5.82%
|
Price to Book
|
1.14
x
|
0.74
x
|
0.47
x
|
0.37
x
|
0.28
x
|
0.27
x
|
Nbr of stocks (in thousands)
|
17,934
|
18,193
|
18,189
|
18,193
|
18,193
|
18,193
|
Reference price
2 |
4,230
|
4,230
|
4,770
|
4,400
|
3,960
|
3,655
|
Announcement Date
|
21/03/19
|
30/03/20
|
25/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
80,295
|
90,386
|
87,494
|
94,675
|
108,089
|
129,877
|
EBITDA
1 |
2,927
|
6,757
|
6,896
|
9,248
|
9,650
|
14,584
|
EBIT
1 |
1,163
|
4,428
|
4,441
|
6,810
|
7,334
|
12,480
|
Operating Margin
|
1.45%
|
4.9%
|
5.08%
|
7.19%
|
6.78%
|
9.61%
|
Earnings before Tax (EBT)
1 |
-89,705
|
47,063
|
101,812
|
35,817
|
43,160
|
1,727
|
Net income
1 |
-69,664
|
36,563
|
79,391
|
28,488
|
38,242
|
-2,970
|
Net margin
|
-86.76%
|
40.45%
|
90.74%
|
30.09%
|
35.38%
|
-2.29%
|
EPS
2 |
-4,260
|
2,037
|
4,365
|
1,566
|
2,102
|
-163.3
|
Free Cash Flow
1 |
-2,576
|
2,976
|
7,375
|
4,303
|
-17,439
|
6,180
|
FCF margin
|
-3.21%
|
3.29%
|
8.43%
|
4.55%
|
-16.13%
|
4.76%
|
FCF Conversion (EBITDA)
|
-
|
44.05%
|
106.94%
|
46.53%
|
-
|
42.38%
|
FCF Conversion (Net income)
|
-
|
8.14%
|
9.29%
|
15.11%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/03/19
|
30/03/20
|
25/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
39,302
|
32,803
|
32,893
|
29,703
|
49,336
|
39,744
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
13.43
x
|
4.855
x
|
4.77
x
|
3.212
x
|
5.113
x
|
2.725
x
|
Free Cash Flow
1 |
-2,576
|
2,976
|
7,375
|
4,303
|
-17,439
|
6,180
|
ROE (net income / shareholders' equity)
|
-70.2%
|
42.5%
|
54.4%
|
14.1%
|
16.3%
|
-1.04%
|
ROA (Net income/ Total Assets)
|
0.4%
|
1.76%
|
1.2%
|
1.42%
|
1.32%
|
2.08%
|
Assets
1 |
-17,359,591
|
2,073,536
|
6,602,726
|
2,001,814
|
2,891,434
|
-142,509
|
Book Value Per Share
2 |
3,716
|
5,733
|
10,207
|
11,823
|
13,943
|
13,720
|
Cash Flow per Share
2 |
102.0
|
332.0
|
260.0
|
313.0
|
220.0
|
436.0
|
Capex
1 |
1,035
|
2,345
|
1,190
|
1,376
|
2,451
|
367
|
Capex / Sales
|
1.29%
|
2.59%
|
1.36%
|
1.45%
|
2.27%
|
0.28%
|
Announcement Date
|
21/03/19
|
30/03/20
|
25/03/21
|
23/03/22
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +48.29% | 71.56M | | -9.51% | 8.77B | | +1.83% | 1.47B | | -9.91% | 1.33B | | -2.02% | 1.22B | | -26.95% | 766M | | +3.73% | 459M | | +1.70% | 431M | | -32.42% | 299M | | -62.86% | 266M |
Medical Equipment Wholesale
|